Pharma Mar SA header image

Pharma Mar SA

PHM

Equity

ISIN ES0169501022 / Valor 56130572

BME Bolsas y Mercados Espanoles - Renta Variable (2026-03-27)

EUR 88.35-2.11%

Pharma Mar SA
UMushroom community rating:

0.00 0 votes No rating yet

NegativeNeutralPositive

About company

Pharma Mar SA, headquartered in Madrid, Spain, is a biopharmaceutical company specializing in the development of oncology drugs derived from marine biodiversity. Established in 1986, the company has a strong focus on researching and developing treatments for rare cancers, leveraging the unique antitumor properties found in marine organisms. Pharma Mar commercializes three main drugs, which, through partnerships with 18 companies, are distributed in over 70 countries. The company has a significant international presence with subsidiaries in Germany, France, Italy, Belgium, Austria, Switzerland, and the United States. Pharma Mar is committed to reinvesting its profits and partner revenues into research and development, as well as the continuous training of its team, to advance its mission of providing innovative cancer therapies.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

8.07%1Y

96.4%3Y

-10.8%5Y

Performance

39.7%1Y

40.6%3Y

40.9%5Y

Volatility

1768 M

Market cap (USD)

184,914

Daily traded volume (Shares)

80.05 / 76.1

1 day high/low (USD)

0.00 / 0.00

52 weeks high/low (USD)

01 January, 2022

Dividend ex-date

0.00

Dividend (USD)

0.00%

Dividend yield (p.a.)

0.002022

0.002023

0.002024

Est dividend (USD)

0.00%2022

0.00%2023

0.00%2024

Est dividend yield

10.00

P/E ratio

00.002022

00.002023

00.002024

Est P/E ratio

0.00

EPS (USD)

0.002022

0.002023

0.002024

Est EPS (USD)

Ratings & reviews

0.00

0 votes

Performance:

0.00

Innovation:

0.00

Society:

0.00

Nature:

0.00

EQUITIES OF THE SAME SECTOR

Intra-Cellular Therapies Inc

Intra-Cellular Therapies Inc Valor: 23194616

Annual Return

-50%0%+50%

Risk level

110

0.00%USD 131.87

Denali Therapeutics Inc

Denali Therapeutics Inc Valor: 39149539

Annual Return

-50%0%+50%

Risk level

110

-7.98%USD 18.16

GE Healthcare Technologies Inc

GE Healthcare Technologies Inc Valor: 123735674

Annual Return

-50%0%+50%

Risk level

110

-3.23%USD 69.23

Option Care Health Inc

Option Care Health Inc Valor: 52359365

Annual Return

-50%0%+50%

Risk level

110

-1.73%USD 27.27

Boiron SA

Boiron SA Valor: 487646

Annual Return

-50%0%+50%

Risk level

110

1.56%EUR 26.00

Laboratorios Farmaceuticos Rovi, SA

Laboratorios Farmaceuticos Rovi, SA Valor: 3591807

Annual Return

-50%0%+50%

Risk level

110

-0.57%EUR 78.90

Roche Holding Ltd

Roche Holding Ltd Valor: 1203204

Annual Return

-50%0%+50%

Risk level

110

-0.10%CHF 312.50

Madrigal Pharmaceuticals Inc

Madrigal Pharmaceuticals Inc Valor: 33395434

Annual Return

-50%0%+50%

Risk level

110

-1.56%USD 510.68

Evotec SE

Evotec SE Valor: 505433

Annual Return

-50%0%+50%

Risk level

110

-1.60%EUR 4.30

Limes Schlosskliniken AG

Limes Schlosskliniken AG Valor: 38625581

Annual Return

-50%0%+50%

Risk level

110

-0.83%EUR 476.00

SIX

FactSet

Clearbit

Logos provided by Clearbit